Neurotropism and Neuroinflammation in COVID-19 Patients With Delirium.

CompletedOBSERVATIONAL
Enrollment

7

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Covid19DeliriumPost-traumatic Stress Disorder
Interventions
BIOLOGICAL

serology testing profiles description

SARS-CoV-2 quasispecies detection and associated serology testing profiles description (peripheral blood and cerebrospinal fluid - CSF)

BIOLOGICAL

immune response characterization

systemic and central immune response characterization , associated to the assessment of CNS damage biomarkers (peripheral blood and CSF)

OTHER

in vivo brain PET-TSPO acquisitions

in vivo brain PET-TSPO acquisitions (Positon Emission Tomography using a radioligand that targets the Translocator Protein, which is upregulated in activated microglia)

OTHER

brain MRI assessment

structural/functional brain MRI assessment (PWI/DWI mismatch imaging, quantification of gray and white matter microstructural integrity, DTI, functional connectivity)

BEHAVIORAL

neurocognitive assessment

multi-domains neurocognitive assessment

Trial Locations (2)

Unknown

University Hospital of Toulouse, Toulouse

CHRU Tours, Tours

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

University Hospital, Toulouse

OTHER